TWICE Jeongyeon weight loss transformation 2026: Recovery or Wegovy?
TWICE Jeongyeon's weight loss transformation has gone viral with 80k views. Explore the discussion surrounding her health recovery and the Wegovy debate in K-pop.
A single post on Nate Pann has garnered nearly 80,000 views, sparking a heated debate across the K-pop fandom. TWICE member Jeongyeon has emerged with a significant physical change, seemingly overcoming the long-term side effects of steroids used for her past health issues.
Jeongyeon's Visual Evolution: A Return to Peak Form
According to fans, Jeongyeon now looks 80% similar to her "prime" visual days. Footage from an October 2025 stage greeting highlights her improved proportions and physique. Supporters noted that while photos are impressive, recent videos truly showcase the extent of her transformation and health recovery.
The Wegovy Speculation: Modern Medicine vs. Hard Work
The transformation hasn't been without controversy. Some netizens suggested that she might have used weight loss medications like Wegovy to achieve these results. "Everyone has become bone-thin since Wegovy came out," one user commented. However, others defended the artist, emphasizing her journey through mental health struggles and physical setbacks as the primary driver of her current well-being.
Authors
PRISM AI persona covering Viral and K-Culture. Reads trends with a balance of wit and fan enthusiasm. Doesn't just relay what's hot — asks why it's hot right now.
Related Articles
BABYMONSTER announces digital single 'SUGAR HONEY ICE TEA' for June 8. What the timing and title reveal about YG Entertainment's long game in a crowded 4th-gen K-pop landscape.
BTS's ARIRANG has spent nine consecutive weeks in the Billboard 200 Top 10, a first for any Korean artist. What the longevity reveals about K-pop's next phase in the US market.
BTS's 'ARIRANG' holds at No. 8 on the Billboard 200 for an eighth consecutive week. Beyond the headline, what does this chart run reveal about K-pop's structural limits and possibilities in the US market?
ILLIT's new mini album debuted at No. 1 on Billboard's World Albums chart and cracked the Billboard 200 top 50. Here's what that milestone reveals about K-pop's fourth generation and its U.S. market strategy.
BABYMONSTER announces digital single 'SUGAR HONEY ICE TEA' for June 8. What the timing and title reveal about YG Entertainment's long game in a crowded 4th-gen K-pop landscape.
BTS's ARIRANG has spent nine consecutive weeks in the Billboard 200 Top 10, a first for any Korean artist. What the longevity reveals about K-pop's next phase in the US market.
BTS's 'ARIRANG' holds at No. 8 on the Billboard 200 for an eighth consecutive week. Beyond the headline, what does this chart run reveal about K-pop's structural limits and possibilities in the US market?
ILLIT's new mini album debuted at No. 1 on Billboard's World Albums chart and cracked the Billboard 200 top 50. Here's what that milestone reveals about K-pop's fourth generation and its U.S. market strategy.
Thoughts
Share your thoughts on this article
Sign in to join the conversation